DOI:
10.1055/s-00000031
Klinische Monatsblätter für Augenheilkunde
LinksClose Window
References
Puliafito CA, Rosenfeld PJ, McCluskey ER.
RhuFab V2 dose escalating trial: safety and tolerability of 3 escalating dosing regimens in subjects with age-related macular degeneration (AMD).
Retina Society Abstract 2003;
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.